Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1634 | Thyroid (non-cancer) | ICEECE2012

Prediction of remission rate in the patients with Graves’ disease after treatment with a minimum maintenance dose of Methimazole

Beniko M. , Ikawa H. , Mori T. , Kudo H. , Matsumoto A. , Sekiguchi M. , Mashio Y.

Introduction: According to the guideline for medical treatment of Graves’ disease by the Japan Thyroid Association in 2011, discontinuation of antithyroid drug is recommended when normal thyroid functions have been maintained for a certain period (≥6 months) after treatment with a minimum maintenance dose (mentioned below). We prospectively studied the remission rates in the patients with Graves’ disease.Methods: The subjects were 108 pat...

ea0026p358 | Steroid metabolism | ECE2011

Chronic effect of 17β estradiol on GLUT4 expression in 3T3-L1 adipocytes

Campello R S , Poletto A C , Furuya D T , Mori R C T , Machado U F

Introduction: Insulin resistance results from a combination of genetic and environmental factors and it may be considered the primary cause of the development of metabolic disorders, such as type 2 diabetes mellitus. It is characterized by a reduced ability of insulin sensitivity tissues to respond to normal levels of the hormone. In these tissues, glucose transport stimulated by insulin occurs through the glucose transporter 4 and alterations in its expression are related to ...